openPR Logo
Press release

Epinephrine Market Bigger Than Expected | Amneal Pharma, Kaleo, Teva Pharmaceuticals, Adamis Pharmaceuticals Corpo, Novartis, Emirade

11-30-2020 01:42 PM CET | Health & Medicine

Press release from: Premium Market Insights

Epinephrine Market to 2027 - Premium Market Insights

Epinephrine Market to 2027 - Premium Market Insights

The global Epinephrine market is anticipated to reach US$ 4,207.88 Mn in 2027 from US$ 2,247.87 Mn in 2019. The market is anticipated to grow with a CAGR of 8.3% from 2020-2027. The report provides trends prevailing in the global epinephrine market and the factors driving the market along with those that act as hindrances.

Epinephrine is a medication used along with emergency medical treatment services for the allergic reactions caused by insect bites or stings, foods, drugs, and latex, among others. It works by relaxing the muscles in the airways and tightening the blood vessels. The injection is available as a prefilled automatic injection device that contains the solution and in vials to inject subcutaneously and others. The injection is generally injected as required at the first sign of a severe allergic reaction.

Get Sample Copy of this Report @ https://www.premiummarketinsights.com/sample/TIP00009622?vin

Novel drug delivery systems aid in improved drug potency and control drug release, and impart a sustained therapeutic effect for greater safety. Many drugs have an optimum concentration range for maximum benefit, and concentrations above or below can be toxic or produce no therapeutic benefit. Moreover, various drug delivery and drug targeting systems are developed to minimize drug degradation and prevent harmful side-effects.

Epinephrine is one such therapeutics, which require an optimum amount of drug injected in the body at the time of anaphylaxis reaction. Any fault in the delivery device can lead to less or no drug delivery in the patient’s body, and such device malfunction can lead to a product recall. For instance, in 2015, Sanofi voluntarily recalled its Auvi-Q (epinephrine injection) due to suspect of the device malfunction, which might be delivering inaccurate dosage. Advancements in epinephrine drug delivery systems are expected to make the patient’s lives easier. People, particularly children, susceptible to acute allergic reactions can find epinephrine injector challenging to keep and use. The novel drug delivery systems are being introduced to help in facilitating the administration of accurate amount of drugs with secure handling.

The global epinephrine market, based on type has been segmented into Prefilled Syringes, Auto-Injectors, Ampoules and Vials. The auto-injectors segment held a largest share of the market in 2019. Moreover, the segment is also anticipated to register the highest CAGR in the market during the forecast period, owing to advantages offered by the product for easy administration during emergency.

The leading companies operating in the epinephrine market include as MYLAN N.V., Abbott, ALK ABELLO, Amneal Pharma, Kaleo, LINCOLN MEDICAL LTD (BioProject), Teva Pharmaceuticals Ltd, Adamis Pharmaceuticals Corporation (Novartis AG), Emirade, and Aurum Pharma (Ethypharm Group Company). Various companies are focusing on organic strategies such as product launch and product approvals. Inorganic growth strategies witnessed in the market were partnerships and acquisition among others. For instance, In December 2016, Mylan N.V. launched authorized generic for EpiPen (epinephrine injection, USP) Auto-Injector. The inorganic strategies adopted by the companies are mergers and acquisitions, collaborations and others.

Interested in purchasing this Report? Click here @ https://www.premiummarketinsights.com/buy/TIP00009622?vin

The report segments the global epinephrine market as follows:

Global Epinephrine Market – By Type

Prefilled Syringes
Auto-Injectors
Ampoules and Vials
Global Epinephrine Market – By Application

Anaphylaxis
Superficial Bleeding
Respiratory Disorders
Cardiac Arrest
Global Epinephrine Market – By Distribution Channel

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global Epinephrine Market – By Geography

North America
US
Canada
Mexico
Europe
France
Germany
U.K
Spain
Italy
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Middle East & Africa (MEA)
Saudi Arabia
U.A.E
South Africa
South & Central America (SCAM)
Brazil
Argentina

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com

About Premium Market Insights:

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epinephrine Market Bigger Than Expected | Amneal Pharma, Kaleo, Teva Pharmaceuticals, Adamis Pharmaceuticals Corpo, Novartis, Emirade here

News-ID: 2198786 • Views:

More Releases from Premium Market Insights

Predictive Maintenance Market Analysis by Recent Developments and Business Outlook 2022-2028
Predictive Maintenance Market Analysis by Recent Developments and Business Outlo …
"The predictive maintenance market is projected to reach US$ 26,588.00 million by 2028 from US$ 5,316.99 million in 2021, growing at a CAGR of 27.4% from 2022 to 2028." According to The Premium Market Insights "Predictive Maintenance Market" report, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The Predictive Maintenance Market Research Reports offers an extensive collection of reports on
Endpoint Security Market Latest Trends, Technology Advancement and Demand 2022 to 2028
Endpoint Security Market Latest Trends, Technology Advancement and Demand 2022 t …
"The endpoint security market is expected to grow from US$ 14,951.39 million in 2022 to US$ 25,073.13 million by 2028; it is estimated to grow at a CAGR of 9.0% from 2022 to 2028." According to The Premium Market Insights "Endpoint Security Market" report, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The Endpoint Security Market Research Reports offers an
E-Learning Market Latest Trends, Advancement and Demands 2022 to 2028
E-Learning Market Latest Trends, Advancement and Demands 2022 to 2028
"The e-learning market is expected to grow from US$ 274.10 billion in 2022 to US$ 465.47 billion by 2028; it is expected to grow at a CAGR of 9.2% from 2022 to 2028." According to The Premium Market Insights "E-Learning Market" report, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The E-Learning Market Research Reports offers an extensive collection of
Investor ESG Software Market Growth and Latest Technology Advancements 2023 to 2030
Investor ESG Software Market Growth and Latest Technology Advancements 2023 to 2 …
"The investor ESG software market size is expected to reach US$ 2,340.13 million by 2030 from 627.85 million in 2022, with an estimated CAGR of 18.3% from 2023 to 2030." According to The Premium Market Insights "Investor ESG Software Market" report, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The Investor ESG Software Market Research Reports offers an extensive collection

All 5 Releases


More Releases for Epinephrine

Epinephrine Market Global Outlook and Top Manufacturers 2020
Global Epinephrine Market Research Report published by market insight reports explores the current market outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries or applications. Historical data from 2014 to 2019 is considered for the analysis and forms the base for the CAGR calculations. The forecasted data is provided from 2020 to 2025 which is derived using primary as well as
Epinephrine Market Report 2018: Segmentation by Type (Epinephrine Auto-injector, …
Global Epinephrine market research report provides company profile for Amphastar, Emerade, Grand Pharma, Harvest Pharmaceuticals, Merit Pharmaceutical, Tianjin Jinyao Group, Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Epinephrine Market Intelligence Report Offers Growth Prospects
Epinephrine or adrenaline is a hormone secreted by adrenal glands in the blood stream. It is one of the two common hormones (the other being glucagon) that is responsible for glycogen breakdown. Secretion of epinephrine is characterized by the presence of extreme emotions such as anxiety or anger thereby resulting in elevated levels of blood pressure along with increased muscle strength and high sugar metabolism. Under strenuous conditions signals are
Epinephrine Market Report Explored in Latest Research
Epinephrine or adrenaline is a hormone secreted by adrenal glands in the blood stream. It is one of the two common hormones (the other being glucagon) that is responsible for glycogen breakdown. Secretion of epinephrine is characterized by the presence of extreme emotions such as anxiety or anger thereby resulting in elevated levels of blood pressure along with increased muscle strength and high sugar metabolism. Under strenuous conditions signals are
Global Epinephrine Autoinjector Industry 2016 Market Research Report
The Global Epinephrine Autoinjector Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Epinephrine Autoinjector industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Epinephrine Autoinjector market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Request Sample Report Here: http://www.reportbazzar.com/request-sample/?pid=569859&ptitle=Global+Epinephrine+Autoinjector+Industry+2016+Market+Research+Report&req=Sample Secondly, development policies and
Global Epinephrine Autoinjector Market Professional Survey Report 2016
Summary This report Mainly covers the following product types For patients using fixed needle syringes For patients using removable needle syringes The segment applications including Segment regions including (the separated region report can also be offered) USA China Europe South America Japan Africa Get Sample Report @ http://www.reportbazzar.com/request-sample/?pid=601286&ptitle=Global+Epinephrine+Autoinjector+Market+Professional+Survey+Report+2016&req=Sample The players list (Partly, Players you are interested in can also be added) Mylan ALK Abello Amedra Pharmaceuticals Sanofi Adamis Pharmaceuticals Owen Mumford Lineage Therapeutics Inc With no less than 15 top producers. Data including (both global and regions): Market Size (both volume – Unit